Publications by authors named "Peter Slootbeek"

Claim this Profile
M
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study.
Iris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer, Sandra van Wilpe, Minke Smits

Br J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of loss-of-function alterations on the response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients.
Peter H J Slootbeek, María Victoria Luna-Velez, Bastiaan M Privé, Maarten J van der Doelen, Iris S H Kloots

Theranostics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?
Peter H J Slootbeek, Sofie H Tolmeijer, Niven Mehra, Jack A Schalken

Crit Rev Clin Lab Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancer.
Peter H J Slootbeek, Joanneke K Overbeek, Marjolijn J L Ligtenberg, Nielka P van Erp, Niven Mehra

Cancer Lett· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer.
Peter H J Slootbeek, Iris S H Kloots, Inge M van Oort, Leonie I Kroeze, Jack A Schalken

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.
Sandra van Wilpe, Donjetë Simnica, Peter Slootbeek, Thomas van Ee, Samhita Pamidimarri Naga

Oncoimmunology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Peter H J Slootbeek, Iris S H Kloots, Minke Smits, Inge M van Oort, Winald R Gerritsen

Br J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Peter H J Slootbeek, Iris S H Kloots, Minke Smits, Inge M van Oort, Winald R Gerritsen

Br J Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer.
Bastiaan M Privé, Peter H J Slootbeek, Babette I Laarhuis, Samhita Pamidimarri Naga, Maarten J van der Doelen

Prostate Cancer Prostatic Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with Ac-PSMA-617 targeted alpha-radiation therapy.
Maarten J van der Doelen, Niven Mehra, Inge M van Oort, Monika G Looijen-Salamon, Marcel J R Janssen, Peter H J Slootbeek

Urol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on "Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer".
Maarten J van der Doelen, Peter H J Slootbeek, Niven Mehra

Eur J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Peter H J Slootbeek, Marleen L Duizer, Maarten J van der Doelen, Iris S H Kloots, Malou C P Kuppen

Int J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.
Maarten J van der Doelen, Pedro Isaacsson Velho, Peter H J Slootbeek, Samhita Pamidimarri Naga, Maren Bormann

Eur J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis